Guangdong-Hong Kong-Macao
Greater Bay Area Biotechnology Alliance
Guangdong-Hong Kong-Macao
Greater Bay Area Biotechnology Alliance
粤港澳大湾区生物科技联盟
Guangdong-Hong Kong-Macao Greater Bay Area Biotechnology Alliance
Hong Kong, as a leading city in Asia offers unprecedented opportunities for biomedical technology, fueled by increased funding and the support from the Hong Kong Government. As we enter the 2020s, Asia is emerging as the world’s next biotech powerhouse. It is a pivotal moment for the development of the biotech sector in the Greater Bay Area (GBA), which is uniquely positioned to contribute to and benefit from Asia’s biotech pool brimming with opportunities. We are committed to letting science lead as foster innovation, promote investment and encourage the entrepreneurial spirit that makes the GBA the global leader in this cutting-edge field.
About Guangdong-Hong Kong-Macao Greater Bay Area
- Guangdong-Hong Kong-Macao Greater Bay Area covers an area of 56,000 square kilometers, with a population of 66 million and has a total economic value close to that of the New York Bay Area
- As these major cities have a great advantage in utilizing scientific and technological achievements for mass productivity, this will be the key to transform the Greater Bay Area into a comprehensive, world-class science and technology innovation center
- This region is going to become the true Southern gate of China, with one end connected to the world and the other end connected to more than 400 million people in the densely populated areas of Western, Central and Southern China. Ultimately, the Guangdong-Hong Kong-Macao Greater Bay Area will be a “super hub” bridge linking China to the rest of the world
What is 9+2?
The Guangdong-Hong Kong-Macao Greater Bay Area (GBA) comprises of the two Special Administrative Regions of Hong Kong and Macao, and the nine municipalities of Guangzhou, Shenzhen, Zhuhai, Foshan, Huizhou, Dongguan, Zhongshan, Jiangmen and Zhaoqing in Guangdong Province.
Upcoming Events
BIOHK2022
Past Events
